Recharging the Human Battery

Company Information





Missoula, MT

BioLight is "recharging the human battery" using the power of red-light therapy.

Perhaps surprisingly, 80% of modern diseases are tied to the same affliction: dysfunctional mitochondria.

This condition happens when our body’s cells don’t get enough natural sunlight. These days, with everyone spending most of their time indoors, surrounded by non-native, “fake” light, that’s a common occurrence.

The good news is that mitochondrial health can be improved using red light therapy, an innovative technique that uses red and near-infrared (NIR) wavelengths to promote health, wellness, and longevity.

BioLight is focusing on this type of therapy with a line of personal red and NIR light devices.

This company is growing fast. In 2019, its revenues were less than $5,000. In 2020, annual revenues reached $344,000. And through July of this year, revenue had already hit more than $500,000.

BioLight has two patents covering its products, and expects to reach 10 patents by the end of this year.

Note: BioLight is "Testing the Waters." That means you can reserve a spot now to ensure you can invest in the company when it opens its official campaign. Reservations are non-binding, so there is no risk in making a reservation.

Team Background

Michael Belkowski - Founder & CEO
$1 million
$9,625 (1%)
Min. Investment
Deal Type
Title III
(For all investors)
Offering Type
Learn more on Republic